Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.
Press releases published on May 29, 2025
Camwood Capital Group Showcases Strategic Talent Additions Supporting 2025 Growth Initiatives
EIN Presswire
·
May 29, 2025
Camwood Capital Group Showcases Strategic Talent Additions Supporting 2025 Growth Initiatives AUSTIN, TX, UNITED STATES, May 29, 2025 /EINPresswire.com/ -- Camwood Capital Group (“Camwood”), a private investment firm focused on long-term value creation …
Smarteeva Announces API Integration Support for FDA's Electronic Submissions Gateway Next Generation
EIN Presswire
·
May 29, 2025
The company became an early adopter of a new cloud-based submission system launched in April 2025. SOUTHLAKE, TX, UNITED STATES, May 29, 2025 /EINPresswire.com/ -- Smarteeva, a leading provider of AI-driven post-market surveillance solutions, today …
Area 52 Becomes First Online Dispensary Shipping Legal Recreational Cannabis to Texas
EIN Presswire
·
May 29, 2025
Area 52 becomes the first online dispensary shipping legal cannabis products – including THC gummies and flower – to Texas. HOUSTON, TX, UNITED STATES, May 29, 2025 /EINPresswire.com/ -- Area 52 becomes the first and only online dispensary shipping …
Unlock Radiant Beauty and Wellness at LifeSculpt by ChristiMD’s ‘Glowing Skin From the Inside Out’ Event
EIN Presswire
·
May 29, 2025
HOUSTON, TX, UNITED STATES, May 29, 2025 /EINPresswire.com/ -- LifeSculpt by ChristiMD invites the public to an exclusive evening of transformation, rejuvenation, and empowerment at “Glowing Skin From the Inside Out,” a signature wellness and aesthetics …
Leading with Light: MUSE Microscopy Illuminates the Next Era of Oncology at ASCO
GlobeNewswire
·
May 29, 2025
IRVINE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- MUSE Microscopy, (the “Company”, “we”, “our”) a leader in slide-free, tissue-to-digital™ pathology solutions, is excited to announce its participation in the upcoming American Society of Clinical Oncology ( …
MediPharm Labs Responds to Fabricated Allegations from Dissident Shareholder
GlobeNewswire
·
May 29, 2025
TORONTO, May 29, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE:MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids, today confirmed that the Company is aware of the news …
Kane Biotech Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 29, 2025
WINNIPEG, Manitoba, May 29, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announces its first quarter 2025 financial results. First Quarter 2025 Financial Highlights (Comparatives Exclude …
Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer
GlobeNewswire
·
May 29, 2025
FREMONT, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- In a move that underscores its dedication to shaping the future of cell analysis, Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced the launch of the Cytek Aurora™ Evo system, a new full spectrum flow …
Tarsus to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 29, 2025
IRVINE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to participate in the following upcoming investor conferences: William Blair 45th Annual Growth Stock Conference on Tuesday, …
Zevra Announces Final Results of 2025 Annual Meeting of Stockholders
GlobeNewswire
·
May 29, 2025
Zevra Stockholders Re-Elect Wendy L. Dixon, Ph.D. and Tamara A. Favorito to the Company’s Board of Directors Board and Management Reaffirm Commitment to Driving Continued Growth and Progress Against Strategic Plan CELEBRATION, Fla., May 29, 2025 (GLOBE …
New Data at ASCO 2025 Affirms DecisionDx®-Melanoma's Ability to Improve Upon Staging-Based Risk Stratification and Predict Survival Outcomes
GlobeNewswire
·
May 29, 2025
FRIENDSWOOD, Texas, May 29, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, will present novel research aimed at enhancing the clinical management of patients …
Dentsply Sirona Appoints Matthew E. Garth as Chief Financial Officer
GlobeNewswire
·
May 29, 2025
CHARLOTTE, N.C., May 29, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Matthew E. Garth has been appointed Executive Vice President and Chief Financial Officer, effective May 30, 2025 …
Femasys Announces Proposed Public Offering of Common Stock and Concurrent Private Placement
GlobeNewswire
·
May 29, 2025
ATLANTA, May 29, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY) (the “Company” or “Femasys”), a leading biomedical innovator addressing significant unmet needs in women’s health worldwide, with a broad portfolio of disruptive, accessible, in-office …
Alumis to Present at the Jefferies Global Healthcare Investor Conference
GlobeNewswire
·
May 29, 2025
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced that Martin Babler, President …
CooperCompanies Announces Second Quarter 2025 Results
GlobeNewswire
·
May 29, 2025
SAN RAMON, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal second quarter ended April 30, 2025. Revenue increased 6% year-over-year to $1,002. …
Fulcrum Therapeutics to Present at Upcoming Medical Meetings
GlobeNewswire
·
May 29, 2025
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare …
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June
GlobeNewswire
·
May 29, 2025
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today …
NextCure and LigaChemBio to Present Trial in Progress Poster for LNCB74, a B7-H4 Targeted Antibody-Drug Conjugate, as Monotherapy in Participants with Advanced Solid Tumors at ASCO 2025
GlobeNewswire
·
May 29, 2025
LNCB74 is in a Phase 1, open-label, first-in-human study that will include dose escalation, safety, and biomarker backfills and randomized dose expansion/optimization The study is currently enrolling in dose escalation Poster to be presented June 2, 2025, …
Vaxart to Participate at the Jefferies Global Healthcare Conference on June 5, 2025
GlobeNewswire
·
May 29, 2025
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that members …
Amneal to Participate at Upcoming Investor Conferences in June
GlobeNewswire
·
May 29, 2025
BRIDGEWATER, N.J., May 29, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) will participate in two upcoming investor conferences: Jefferies Global Healthcare Conference on June 5, 2025, with company presentation at 9:20 AM ET, and …